Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy

Background and Aim: Extracellular vesicles (EVs) are key players in cellular communication and signaling in the health status and diseases. EVs have rather small size and long half-life upon secretion into circulation. This long half-life along with their immune privileged profile and the ability to...

Full description

Bibliographic Details
Main Authors: jamal majidpoor, fardin fathi, Keywan Mortezaee
Format: Article
Language:fas
Published: Kurdistan University of Medical Sciences 2023-10-01
Series:مجله علمی دانشگاه علوم پزشکی کردستان
Subjects:
Online Access:http://sjku.muk.ac.ir/article-1-7635-en.pdf
_version_ 1797285586089803776
author jamal majidpoor
fardin fathi
Keywan Mortezaee
author_facet jamal majidpoor
fardin fathi
Keywan Mortezaee
author_sort jamal majidpoor
collection DOAJ
description Background and Aim: Extracellular vesicles (EVs) are key players in cellular communication and signaling in the health status and diseases. EVs have rather small size and long half-life upon secretion into circulation. This long half-life along with their immune privileged profile and the ability to carry biotherapeutics to the target cells have made EVs an issue of prominent current interest among scientists as an alternative schedule in cancer therapy. Materials and Methods: PubMed and Google scholar were searched for relevant articles from journals with high impact factor. Among 400 articles found, 40 articles met the criteria for interpretation and were selected for descriptive review. Original and review articles published in the last ten years were used in this study. Results: Tumor-derived EVs can be targeted for reducing cancer cell survival and increasing their apoptosis. They are also applicable for drug delivery to primary or metastatic tumors. An effective approach is to load nanoparticles into EVs for targeting a specific cell type in tumor ecosystem. Their application in nano delivery systems for cancer therapy has been the focus of attention. Conclusion: The current studies have focused on the possibility of using EVs as biomarkers in several diseases, as targets to be removed for recovery of the patient health, and as vehicles for immunotherapy. In this review article, we discussed the importance of EV suppression or EV-based strategy for targeting solid cancers
first_indexed 2024-03-07T18:05:19Z
format Article
id doaj.art-2eb42826e18a4589b7f8271a9c57214a
institution Directory Open Access Journal
issn 1560-652X
2345-4040
language fas
last_indexed 2024-03-07T18:05:19Z
publishDate 2023-10-01
publisher Kurdistan University of Medical Sciences
record_format Article
series مجله علمی دانشگاه علوم پزشکی کردستان
spelling doaj.art-2eb42826e18a4589b7f8271a9c57214a2024-03-02T09:28:13ZfasKurdistan University of Medical Sciencesمجله علمی دانشگاه علوم پزشکی کردستان1560-652X2345-40402023-10-01284160173Strategies for Application of Extracellular Vesicles in Solid Cancer Therapyjamal majidpoor0fardin fathi1Keywan Mortezaee2 Department of Anatomy, School of Medicine, Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Background and Aim: Extracellular vesicles (EVs) are key players in cellular communication and signaling in the health status and diseases. EVs have rather small size and long half-life upon secretion into circulation. This long half-life along with their immune privileged profile and the ability to carry biotherapeutics to the target cells have made EVs an issue of prominent current interest among scientists as an alternative schedule in cancer therapy. Materials and Methods: PubMed and Google scholar were searched for relevant articles from journals with high impact factor. Among 400 articles found, 40 articles met the criteria for interpretation and were selected for descriptive review. Original and review articles published in the last ten years were used in this study. Results: Tumor-derived EVs can be targeted for reducing cancer cell survival and increasing their apoptosis. They are also applicable for drug delivery to primary or metastatic tumors. An effective approach is to load nanoparticles into EVs for targeting a specific cell type in tumor ecosystem. Their application in nano delivery systems for cancer therapy has been the focus of attention. Conclusion: The current studies have focused on the possibility of using EVs as biomarkers in several diseases, as targets to be removed for recovery of the patient health, and as vehicles for immunotherapy. In this review article, we discussed the importance of EV suppression or EV-based strategy for targeting solid cancershttp://sjku.muk.ac.ir/article-1-7635-en.pdfextracellular vesicle (ev)exosomecancertherapy
spellingShingle jamal majidpoor
fardin fathi
Keywan Mortezaee
Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
مجله علمی دانشگاه علوم پزشکی کردستان
extracellular vesicle (ev)
exosome
cancer
therapy
title Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
title_full Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
title_fullStr Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
title_full_unstemmed Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
title_short Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
title_sort strategies for application of extracellular vesicles in solid cancer therapy
topic extracellular vesicle (ev)
exosome
cancer
therapy
url http://sjku.muk.ac.ir/article-1-7635-en.pdf
work_keys_str_mv AT jamalmajidpoor strategiesforapplicationofextracellularvesiclesinsolidcancertherapy
AT fardinfathi strategiesforapplicationofextracellularvesiclesinsolidcancertherapy
AT keywanmortezaee strategiesforapplicationofextracellularvesiclesinsolidcancertherapy